ERIC DOBMEIER - 18 Aug 2021 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC.

Role: President, CEO, Director
Signature: /s/ Kirk Schumacher, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 18 Aug 2021
Net transactions value: +$118,163
Form type: 4
Filing time: 19 Aug 2021, 17:55:10 UTC
Previous filing: 15 Jun 2021
Next filing: 22 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KDNY	Common Stock	Purchase	$82,163	+7,000	+7.2%	$11.74	104,837	18 Aug 2021	Direct	F1
transaction	KDNY	Common Stock	Purchase	$36,000	+3,000	+2.9%	$12.00	107,837	19 Aug 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.45 to $12.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.45 to $12.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.